<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK52764" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK52764/" /><meta name="ncbi_pagename" content="Capillary Malformation-Arteriovenous Malformation Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Capillary Malformation-Arteriovenous Malformation Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Capillary Malformation-Arteriovenous Malformation Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/09/12" /><meta name="citation_author" content="Pinar Bayrak-Toydemir" /><meta name="citation_author" content="David Stevenson" /><meta name="citation_pmid" content="21348050" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK52764/" /><meta name="citation_keywords" content="CM-AVM Syndrome" /><meta name="citation_keywords" content="CM-AVM Syndrome" /><meta name="citation_keywords" content="RASA1 Parkes Weber Syndrome" /><meta name="citation_keywords" content="Ephrin type-B receptor 4" /><meta name="citation_keywords" content="Ras GTPase-activating protein 1" /><meta name="citation_keywords" content="EPHB4" /><meta name="citation_keywords" content="RASA1" /><meta name="citation_keywords" content="Capillary Malformation-Arteriovenous Malformation Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Capillary Malformation-Arteriovenous Malformation Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Pinar Bayrak-Toydemir" /><meta name="DC.Contributor" content="David Stevenson" /><meta name="DC.Date" content="2019/09/12" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK52764/" /><meta name="description" content="Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb)." /><meta name="og:title" content="Capillary Malformation-Arteriovenous Malformation Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK52764/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/rasa1-rel-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK52764/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B9F1CDFC880410000000005740286.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK52764_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK52764_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cantu/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ca5a-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK52764_"><span class="title" itemprop="name">Capillary Malformation-Arteriovenous Malformation Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: CM-AVM Syndrome</div><p class="contrib-group"><span itemprop="author">Pinar Bayrak-Toydemir</span>, MD, PhD, FACMG and <span itemprop="author">David Stevenson</span>, MD, FACMG.</p><a data-jig="ncbitoggler" href="#__NBK52764_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK52764_ai__"><div class="contrib half_rhythm"><span itemprop="author">Pinar Bayrak-Toydemir</span>, MD, PhD, FACMG<div class="affiliation small">Department of Pathology<br />University of Utah<br />ARUP Laboratories<br />Salt Lake City, Utah<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.balpura@rimedyot-karyab.ranip" class="oemail">moc.balpura@rimedyot-karyab.ranip</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David Stevenson</span>, MD, FACMG<div class="affiliation small">Division of Medical Genetics<br />Stanford University<br />Palo Alto, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.drofnats@nevetsad" class="oemail">ude.drofnats@nevetsad</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 22, 2011</span>; Last Update: <span itemprop="dateModified">September 12, 2019</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="rasa1-rel-dis.Summary" itemprop="description"><h2 id="_rasa1-rel-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CM-AVM syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>EPHB4</i> or <i>RASA1</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> For capillary malformations and telangiectases that are of cosmetic concern, referral to a dermatologist. For AVMs and AVFs, the risks and benefits of intervention (embolization vs surgery) must be considered, usually with input from a multidisciplinary team (e.g., specialists in interventional radiology, neurosurgery, surgery, cardiology, and dermatology). For cardiac overload, referral to a cardiologist. For hemihyperplasia and/or leg-length discrepancy, referral to an orthopedist. Lymphangiography to evaluate for lymphatic malformations may be considered; compression stockings for those with evidence of lymphedema; epistaxis treatment includes humidification, nasal lubricants, referral to otolaryngologist, and complete blood count for evaluation of anemia.</p><p><i>Surveillance:</i> Repeat imaging studies if clinical signs/symptoms of AVMs/AVFs become evident.</p><p><i>Evaluation of relatives at risk:</i> Clarification of the genetic status of at-risk relatives is appropriate in order to allow early diagnosis and treatment of AVMs/AVFs to reduce/avoid secondary adverse outcomes.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CM-AVM syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. For <i>RASA1</i>-CM-AVM syndrome, about 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have an affected parent; about 30% have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. For <i>EPHB4-</i>CM-AVM syndrome, about 80% of affected individuals have an affected parent; about 20% have a <i>de novo</i> pathogenic variant. Each child of an individual with CM-AVM syndrome has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the pathogenic variant has been identified in an affected family member.</p></div></div><div id="rasa1-rel-dis.GeneReview_Scope"><h2 id="_rasa1-rel-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="rasa1-rel-dis.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK52764/table/rasa1-rel-dis.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rasa1-rel-dis.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rasa1-rel-dis.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Capillary Malformation-Arteriovenous Malformation Syndrome: Additional Included Phenotype&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_rasa1-rel-dis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>RASA1</i> Parkes Weber syndrome</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#rasa1-rel-dis.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="rasa1-rel-dis.TF.c.1"><p class="no_margin">For other genetic causes of this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> see <a href="#rasa1-rel-dis.Management">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="rasa1-rel-dis.Diagnosis"><h2 id="_rasa1-rel-dis_Diagnosis_">Diagnosis</h2><p>Diagnostic criteria for capillary malformation-arteriovenous malformation (CM-AVM) syndrome have been proposed but not systematically evaluated [<a class="bk_pop" href="#rasa1-rel-dis.REF.orme.2013.409">Orme et al 2013</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.weitz.2015.76">Weitz et al 2015</a>].</p><div id="rasa1-rel-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>CM-AVM syndrome <b>should be suspected</b> in individuals who have <b>any</b> of the following:</p><ul><li class="half_rhythm"><div><b>Capillary malformations (CMs),</b> the hallmark of CM-AVM syndrome. CMs are generally:</div><ul><li class="half_rhythm"><div>Multifocal, atypical pink-to-reddish brown, multiple, small (1-2 cm in diameter), round-to-oval lesions sometimes with a white halo;</div></li><li class="half_rhythm"><div>Composed of dilated capillaries in the papillary dermis [<a class="bk_pop" href="#rasa1-rel-dis.REF.hershkovitz.2008b.385">Hershkovitz et al 2008b</a>];</div></li><li class="half_rhythm"><div>Mostly localized on the face and limbs;</div></li><li class="half_rhythm"><div>Seen in combination with arteriovenous malformations (AVMs) or arteriovenous fistulas (AVF), but may be the only finding [<a class="bk_pop" href="#rasa1-rel-dis.REF.hershkovitz.2008a.1035">Hershkovitz et al 2008a</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</a>].</div></li></ul></li><li class="half_rhythm"><div><b>AVMs/AVFs</b> in soft tissue, bone, and brain that may be associated with overgrowth [<a class="bk_pop" href="#rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al 2003</a>]</div></li><li class="half_rhythm"><div><b>Parkes Weber syndrome <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>,</b> a cutaneous capillary malformation associated with underlying multiple micro-AVFs and soft-tissue and skeletal hypertrophy of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> limb [<a class="bk_pop" href="#rasa1-rel-dis.REF.mulliken.1988">Mulliken &#x00026; Young 1988</a>]</div></li></ul></div><div id="rasa1-rel-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a CM-AVM syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>EPHB4</i> or <i>RASA1</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK52764/table/rasa1-rel-dis.T.molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figrasa1reldisTmoleculargenetictestin" rid-ob="figobrasa1reldisTmoleculargenetictestin">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of CM-AVM syndrome is broad, individuals with the distinctive findings described in <a href="#rasa1-rel-dis.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#rasa1-rel-dis.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with capillary malformations and/or AVMs are more likely to be diagnosed using genomic testing (see <a href="#rasa1-rel-dis.Option_2">Option 2</a>).</p><div id="rasa1-rel-dis.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of CM-AVM syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>. A multigene panel that includes <i>EPHB4</i>, <i>RASA1</i>, and other genes of interest (see <a href="#rasa1-rel-dis.Management">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK52764/table/rasa1-rel-dis.T.molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figrasa1reldisTmoleculargenetictestin" rid-ob="figobrasa1reldisTmoleculargenetictestin">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Note:</b> (1) In <i>RASA1</i>-CM-AVM syndrome, ~30% of probands have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>]; in <i>EPHB4</i>-CM-AVM syndrome, ~20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a <i>de novo</i> pathogenic variant [<a class="bk_pop" href="#rasa1-rel-dis.REF.vivanti.2018.979">Vivanti et al 2018</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>]; therefore, testing of parental samples for variants identified in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may be helpful for the interpretation of the variant. (2) Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a <i>de novo</i>
<i>EPHB4</i> pathogenic variant (identified in ~20% of blood cells) has been reported [<a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>]; therefore, detection of mosaicism should be considered in assay selection and development.</p></div><div id="rasa1-rel-dis.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by capillary malformations and/or arteriovenous malformations, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is another option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic &#x02013; and particularly when evidence supports <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance &#x02013; <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="rasa1-rel-dis.T.molecular_genetic_testin" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Capillary Malformation-Arteriovenous Malformation (CM-AVM) Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK52764/table/rasa1-rel-dis.T.molecular_genetic_testin/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rasa1-rel-dis.T.molecular_genetic_testin_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of CM-AVM Syndrome Attributed to Pathogenic Variants in Gene</th><th id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>3</sup> Detectable by Method</th></tr><tr><th headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3" id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3" id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EPHB4</i></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%&#x000a0;<sup>6</sup></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3 hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">54/54&#x000a0;<sup>6</sup></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3 hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RASA1</i></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50%&#x000a0;<sup>7</sup></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3 hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~92%&#x000a0;<sup>7,&#x000a0;8</sup></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3 hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~8%&#x000a0;<sup>7,&#x000a0;8</sup></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~40%&#x000a0;<sup>6</sup></td><td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3 hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_1 hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="rasa1-rel-dis.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="rasa1-rel-dis.TF.1.2"><p class="no_margin">See <a href="/books/NBK52764/#rasa1-rel-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="rasa1-rel-dis.TF.1.3"><p class="no_margin">See <a href="#rasa1-rel-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in these genes.</p></div></dd><dt>4. </dt><dd><div id="rasa1-rel-dis.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="rasa1-rel-dis.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="rasa1-rel-dis.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al [2017]</a> reported 54 index patients identified by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></div></dd><dt>7. </dt><dd><div id="rasa1-rel-dis.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</a></p></div></dd><dt>8. </dt><dd><div id="rasa1-rel-dis.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2018.1521">Wooderchak-Donahue et al [2018]</a></p></div></dd></dl></div></div></div></div></div></div><div id="rasa1-rel-dis.Clinical_Characteristics"><h2 id="_rasa1-rel-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="rasa1-rel-dis.Clinical_Description"><h3>Clinical Description</h3><p>The clinical manifestations of <i>RASA1-</i>capillary malformation-arteriovenous malformation (<i>RASA1</i>-CM-AVM) syndrome have been described in many individuals with large cohorts by <a class="bk_pop" href="#rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al [2003]</a> (n=39), <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</a> (n=101), and <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</a> (n=138), with insights from a number of other case series and case reports [<a class="bk_pop" href="#rasa1-rel-dis.REF.hershkovitz.2008a.1035">Hershkovitz et al 2008a</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.hershkovitz.2008b.385">Hershkovitz et al 2008b</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.thiex.2010.775">Thiex et al 2010</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.carr.2011.1640">Carr et al 2011</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.buhl.2012.1334">Buhl et al 2012</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.de_wijn.2012.191">de Wijn et al 2012</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2012.91">Wooderchak-Donahue et al 2012</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.burrows.2013.8621">Burrows et al 2013</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.catal_.2013.710">Catal&#x000e0; et al 2013</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.durrington.2013.1690">Durrington et al 2013</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.kim.2015.128">Kim et al 2015</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.maruani.2018.251">Maruani et al 2018</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2018.1521">Wooderchak-Donahue et al 2018</a>].</p><p>The clinical manifestations of <i>EPHB4</i> capillary malformation-arteriovenous malformation (<i>EPHB4-</i>CM-AVM) syndrome have been described in two studies by <a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al [2017]</a> (n=102), and <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al [2019]</a> (n=10).</p><p>Significant intra- and <a class="def" href="/books/n/gene/glossary/def-item/interfamilial-variability/">interfamilial variability</a> in the existence and location of vascular malformations has been described.</p><div id="rasa1-rel-dis.T.features_of_capillary_ma" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Features of Capillary Malformation-Arteriovenous Malformation</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK52764/table/rasa1-rel-dis.T.features_of_capillary_ma/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rasa1-rel-dis.T.features_of_capillary_ma_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" style="text-align:left;vertical-align:middle;">Feature</th><th id="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:top;">% of Persons with Feature by Associated Gene</th></tr><tr><th headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2" id="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:top;"><i>RASA1-</i>CM-AVM&#x000a0;<sup>1</sup></th><th headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2" id="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>EPHB4-</i>CM-AVM&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><b>Capillary malformations</b></td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~97%</td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">100%</td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Arteriovenous</b><br /><b>malformations/</b><br /><b>arteriovenous fistulas&#x000a0;<sup>3</sup></b></td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~24% includes:
<ul><li class="half_rhythm"><div>13% extra-CNS</div></li><li class="half_rhythm"><div>10% intra-CNS</div></li></ul></td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">~18% includes:
<ul><li class="half_rhythm"><div>Mostly AVM &#x00026; extracranial</div></li><li class="half_rhythm"><div>1% vein of Galen aneurysmal malformation</div></li></ul></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><b>Parkes Weber syndrome</b></td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8%</td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">8%</td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><b>Bier spots</b></td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">12%</td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><b>Telangiectasias (upper</b><br /><b>thorax, lips, or arms/legs)</b></td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">~80%&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><b>Epistaxis</b></td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported</td><td headers="hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_1_2 hd_h_rasa1-rel-dis.T.features_of_capillary_ma_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">~60%&#x000a0;<sup>2</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="rasa1-rel-dis.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</a></p></div></dd><dt>2. </dt><dd><div id="rasa1-rel-dis.TF.2.2"><p class="no_margin">An ascertainment bias exists for the two studies included. In the first large study individuals were ascertained for CM-AVM syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>], and in the second small study for hereditary hemorrhagic telangiectasia [<a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>]. In this second group, epistaxis and telangiectasia ratio was higher than in the first study (epistaxis: 6/10 individuals; telangiectasia: 8/10 individuals; CM: 8/10 individuals).</p></div></dd><dt>3. </dt><dd><div id="rasa1-rel-dis.TF.2.3"><p class="no_margin">Not all individuals with CM-AVM syndrome are likely to have had comprehensive imaging studies; therefore, the frequency of AVMs/AVFs is difficult to determine.</p></div></dd></dl></div></div></div><div id="rasa1-rel-dis.Capillary_Malformations_CM"><h4>Capillary Malformations (CMs)</h4><p>CMs are multiple round or oval pink lesions often with a blanched halo. CMs can be present at birth and tend to increase in number over time.</p><p>Arterial flow with Doppler ultrasound has been reported over the CMs [<a class="bk_pop" href="#rasa1-rel-dis.REF.kim.2015.128">Kim et al 2015</a>] and is hypothesized to be a manifestation of an underlying AVM. It is unclear if arterial flow abnormalities associated with the CMs can increase or develop over time.</p></div><div id="rasa1-rel-dis.Arteriovenous_Malformation"><h4>Arteriovenous Malformations / Arteriovenous Fistulas (AVMs/AVFs)</h4><p>Current data on long-term development of AVMs/AVFs after initial screening are insufficient. Although it has been hypothesized that AVMs/AVFs may develop over time [<a class="bk_pop" href="#rasa1-rel-dis.REF.orme.2013.409">Orme et al 2013</a>], to date no individuals who had normal imaging screens have subsequently been reported to have developed AVMs/AVFs.</p><p><b>Intracranial</b> AVMs/AVFs can manifest early in life [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</a>]. Vein of Galen aneurysmal malformation and other intracranial AVMs have led to seizures, hydrocephalus, migraine headaches, and cardiac failure [<a class="bk_pop" href="#rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al 2003</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.grillner.2016.709">Grillner et al 2016</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>]. <a class="bk_pop" href="#rasa1-rel-dis.REF.vivanti.2018.979">Vivanti et al [2018]</a> reported on a series of 19 children with vein of Galen malformation; 10% had <i>EPHB4</i> pathogenic variants.</p><p><a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</a> reported that most of the intracranial lesions were macrofistulas causing symptoms in infancy. However, this finding may be biased given that the identification of the AVMs/AVFs may be secondary to associated symptoms and that asymptomatic individuals may not have had the imaging studies needed to detect the lesions.</p><p><b>Extracranial</b> AVMs and AVFs are typically reported in skin, muscle, and spine.</p><p>Although approximately 50% of AVMs/AVFs have been reported to be in the head/neck region [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</a>], the frequency of AVMs/AVFs in this location may be an overestimate because it is likely that imaging is preferentially performed in this region.</p><p>Symptomatic intraspinal AVMs resulting in neurologic deficits have been reported; MRI has identified intraspinous lesions requiring endovascular/surgical treatment [<a class="bk_pop" href="#rasa1-rel-dis.REF.thiex.2010.775">Thiex et al 2010</a>].</p><p>AVMs/AVFs have not been commonly reported in viscera [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>], a distinguishing difference from <a href="/books/n/gene/hht/">hereditary hemorrhagic telangiectasia</a>.</p></div><div id="rasa1-rel-dis.Parkes_Weber_Syndrome"><h4>Parkes Weber Syndrome</h4><p>Limb overgrowth has been reported in both the upper and lower extremities in individuals with CM-AVM syndrome. The overgrowth is typically noticeable in infancy and can range in severity. Most individuals with limb overgrowth fulfill the findings of Parkes Weber syndrome, defined by <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</a> as the presence of a capillary stain, bony and soft tissue hyperplasia, and multiple arteriolovenular microfistulas throughout an upper or lower extremity [<a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>].</p></div><div id="rasa1-rel-dis.Other"><h4>Other</h4><p><b>Bier spots,</b> white spots on the skin surrounded by a pale halo of erythema, have been described in individuals with <i>EPHB4</i>-CM-AVM syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>].</p><p><b>Telangiectasia</b> has been reported primarily in individuals with <i>EPHB4-</i>CM-AVM syndrome. The telangiectases were typically located on the lips, trunks, and/or arms/legs [<a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>].</p><p><b>Epistaxis</b> has been reported in individuals with <i>EPHB4-</i>CM-AVM syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>].</p><p><b>Cardiac</b>
<b>overload/failure</b> is a potential complication in individuals with significant fast-flow lesions.</p><p>In particular, one third of individuals with <i>RASA1</i> Parkes Weber syndrome required cardiac follow up [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>].</p><p>One infant with <i>RASA1</i>-CM-AVM syndrome had an AVF between the left carotid artery and jugular vein that caused cardiac overload requiring treatment [<a class="bk_pop" href="#rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al 2003</a>].</p><p>One woman with <i>RASA1</i>-CM-AVM syndrome reported worsening of symptoms during pregnancy; she developed pulmonary and peripheral edema with concern for high-output heart failure that resolved after pregnancy [<a class="bk_pop" href="#rasa1-rel-dis.REF.durrington.2013.1690">Durrington et al 2013</a>].</p><p>Nonimmune hydrops fetalis due to an AVM has been reported in <i>RASA1</i>-CM-AVM syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.overcash.2015.2440">Overcash et al 2015</a>].</p><p>Congenital heart defects have been reported in a few individuals with <i>RASA1-</i> and <i>EPHB4-</i>CM-AVM syndrome; however, this finding may be coincidental [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.martinalmedina.2016.3080">Martin-Almedina et al 2016</a>].</p><p><b>Lymphatic malformations</b> have been reported in several individuals with <i>EPHB4-</i> and <i>RASA1</i>-CM-AVM syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.de_wijn.2012.191">de Wijn et al 2012</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.burrows.2013.8621">Burrows et al 2013</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.macmurdo.2016.1450">Macmurdo et al 2016</a>]. Lymphangiography and near-infrared fluorescence lymphatic imaging showed abnormally dilated collecting lymphatics with sluggish flow in the unaffected limb, and tortuous lymphatics of the affected limb with lymphocele-like vesicles in the groin of individuals with <i>RASA1</i>-CM-AVM syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.burrows.2013.8621">Burrows et al 2013</a>]. Whether these lymphatic abnormalities are progressive is not yet known. An <i>EPHB4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in a four-generation <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> with central conducting lymphatic anomaly [<a class="bk_pop" href="#rasa1-rel-dis.REF.li.2018.3233">Li et al 2018</a>]. Hydrops fetalis was reported in individuals from two families with <i>EPHB4-</i>CM-AVM syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.martinalmedina.2016.3080">Martin-Almedina et al 2016</a>].</p><p><b>Tumors.</b> Individuals with <i>RASA1</i>-CM-AVM syndrome may be at increased risk for tumor development, but review of the reported cases does not confirm this: <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</a> reported several different types of tumors (e.g., optic glioma, lipoma, superficial basal cell carcinoma, angiolipoma, non-small-cell lung cancer, and vestibular schwannoma) in 44 families; however, in their larger series of 138 individuals, the only tumors reported were two common basal cell carcinomas in two individuals from the same family [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</a>]. Whether the rate of tumors is increased compared to the general population is as yet unknown, but it is likely not dramatically increased.</p><p><b>Additional</b> findings observed in a small number of individuals with <i>RASA1</i>-CM-AVM syndrome include seizures, headaches, hydrocephalus, neurogenic bladder, varicosities, and hemangiomas. It is not clear if these findings are primary manifestations of a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>RASA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, secondary complications of AVMs/AVFs, or unrelated.</p></div></div><div id="rasa1-rel-dis.GenotypePhenotype_Correlat"><h3>Genotype-Phenotype Correlations</h3><p>Studies to date are insufficient to identify <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>.</p></div><div id="rasa1-rel-dis.Penetrance"><h3>Penetrance</h3><p><b><i>EPHB4.</i></b> Penetrance of <i>EPHB4-</i>CM-AVM syndrome was reported to be 93% (102 of 110 individuals) in one study by <a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al [2017]</a>.</p><p><b><i>RASA1.</i></b> Penetrance is 90%-99% for <i>RASA1</i>-CM-AVM syndrome. <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</a> determined that 55 of 57 individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>RASA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> were <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. <a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</a> determined that 136 of 138 individuals heterozygous for a germline <i>RASA1</i> pathogenic variant had multiple CMs.</p></div><div id="rasa1-rel-dis.Nomenclature"><h3>Nomenclature</h3><p><a class="bk_pop" href="#rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al [2003]</a> named the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> caused by <i>RASA1</i> pathogenic variants "capillary malformation-arteriovenous malformation" (CM-AVM) syndrome. Later, <a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al [2017]</a> named the phenotype caused by <i>RASA1</i> pathogenic variants "capillary malformation-arteriovenous malformation 1" (CM-AVM1) and the phenotype caused by <i>EPHB4</i> pathogenic variants "capillary malformation-arteriovenous malformation 2" (CM-AVM2).</p></div><div id="rasa1-rel-dis.Prevalence"><h3>Prevalence</h3><p>Prevalence of CM-AVM syndrome is estimated at 1:100,000 in northern Europeans [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>]. Another estimate of prevalence using the Exome Aggregation Consortium dataset is around 1:20,000 (<i>RASA1</i>-CM-AVM syndrome) and 1:12,000 (<i>EPHB4-</i>CM-AVM syndrome) [<a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>].</p></div></div><div id="rasa1-rel-dis.Differential_Diagnosis"><h2 id="_rasa1-rel-dis_Differential_Diagnosis_">Differential Diagnosis</h2><div id="rasa1-rel-dis.T.other_genes_of_interest" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Other Genes of Interest in the Differential Diagnosis of Capillary Malformation-Arteriovenous Malformation (CV-AVM) Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK52764/table/rasa1-rel-dis.T.other_genes_of_interest/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rasa1-rel-dis.T.other_genes_of_interest_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Differential Diagnosis Disorder</th><th id="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="background-color:rgb(242,242,242);text-align:center;vertical-align:middle;">Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4" id="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Overlapping w/CV-AVM syndrome</th><th headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4" id="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_2" scope="col" rowspan="1" colspan="1" style="background-color:rgb(242,242,242);text-align:left;vertical-align:middle;">Distinguishing from CV-AVM syndrome</th></tr></thead><tbody><tr><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACVRL</i>&#x000a0;<sup>1</sup><br /><i>ENG</i>&#x000a0;<sup>1</sup><br /><i>GDF2</i>&#x000a0;<sup>1</sup><br /><i>SMAD4</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hht/">Hereditary hemorrhagic telangiectasia</a></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple AVMs that lack intervening capillaries &#x00026; result in direct connections between arteries &#x00026; veins</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Spontaneous &#x00026; recurrent nosebleeds (epistaxis) are more common.</div></li><li class="half_rhythm"><div>Telangiectases generally only on lips, nose, &#x00026; hands</div></li><li class="half_rhythm"><div>~25% may have GI bleeding later in life.</div></li><li class="half_rhythm"><div>Large capillary malformations are not typical.</div></li></ul></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNAQ</i></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sturge-Weber syndrome (SWS)<br />(OMIM <a href="http://omim.org/entry/185300" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">185300</a>)</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See<br />footnote 2</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intracranial vascular anomaly&#x000a0;<sup>3</sup></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Segmental facial cutaneous vascular malformations (port-wine stains), seizures, &#x00026; glaucoma&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PIK3CA</i></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Klippel-Trenaunay-Weber syndrome&#x000a0;<sup>5</sup></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See<br />footnote 6</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMs &#x00026; hypertrophy of the related bones &#x00026; soft tissues</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vascular malformations are typically low-flow lesions w/out high-flow AVMs.&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PTEN</i></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/phts/"><i>PTEN</i> hamartoma tumor syndromes</a>&#x000a0;<sup>8</sup></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overgrowth &#x00026; fast-flow lesions</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Vascular anomalies are usually intramuscular, associated w/ectopic fat, &#x00026; severely disrupt tissue architecture.&#x000a0;<sup>9</sup></div></li><li class="half_rhythm"><div>Tumor predisposition is more prominent.</div></li></ul></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TEK</i></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/vmcm/">Multiple cutaneous and mucosal venous malformations</a></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cutaneous VMs can be mistaken for CMs.</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Small, multifocal bluish cutaneous &#x00026;/or mucosal VMs, usually present at birth. New lesions appear w/time.</div></li><li class="half_rhythm"><div>Small lesions are usually asymptomatic; larger lesions can invade subcutaneous muscle &#x00026; cause pain.</div></li></ul></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GLMN</i></td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hereditary glomuvenous malformations (GVMs) (OMIM <a href="http://omim.org/entry/138000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">138000</a>)</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cutaneous VMs can be mistaken for CMs.</td><td headers="hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_1_4 hd_h_rasa1-rel-dis.T.other_genes_of_interest_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Although clinically GVM can look like any VM, GVMs are more painful on palpation, only partially compressible, &#x00026; usually not found in mucosa.&#x000a0;<sup>10</sup></div></li><li class="half_rhythm"><div>Lesions consist of glomus cells.</div></li><li class="half_rhythm"><div>Familial aggregation is more common in hereditary GVM than in VMs generally.</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AVM = arteriovenous malformation; CM = capillary malformation; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; VM = venous malformation</p></div></dd><dt>1. </dt><dd><div id="rasa1-rel-dis.TF.3.1"><p class="no_margin">The known hereditary hemorrhagic telangiectasia-related genes are involved in the TGF-&#x003b2;/BMP signaling cascade.</p></div></dd><dt>2. </dt><dd><div id="rasa1-rel-dis.TF.3.2"><p class="no_margin">Somatic mosaic mutation of <i>GNAQ</i> has been reported in individuals with Sturge-Weber syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.shirley.2013.1971">Shirley et al 2013</a>].</p></div></dd><dt>3. </dt><dd><div id="rasa1-rel-dis.TF.3.3"><p class="no_margin">Leptomeningeal angiomatosis most often involves the occipital and posterior parietal lobes.</p></div></dd><dt>4. </dt><dd><div id="rasa1-rel-dis.TF.3.4"><p class="no_margin">No <i>RASA1</i> pathogenic variants were identified in nine persons with SWS who represented <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) [<a class="bk_pop" href="#rasa1-rel-dis.REF.zhou.2011.603">Zhou et al 2011</a>] or in 37 individuals with SWS [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</a>].</p></div></dd><dt>5. </dt><dd><div id="rasa1-rel-dis.TF.3.5"><p class="no_margin">Also referred to as Klippel-Trenaunay syndrome (KTS)</p></div></dd><dt>6. </dt><dd><div id="rasa1-rel-dis.TF.3.6"><p class="no_margin">Mosaic variants in <i>PIK3CA</i> have been reported in KTS [<a class="bk_pop" href="#rasa1-rel-dis.REF.vahidnezhad.2016.17">Vahidnezhad et al 2016</a>].</p></div></dd><dt>7. </dt><dd><div id="rasa1-rel-dis.TF.3.7"><p class="no_margin">Diagnostic criteria for KTS have been proposed [<a class="bk_pop" href="#rasa1-rel-dis.REF.oduber.2008.217">Oduber et al 2008</a>]. To date no <i>RASA1</i> pathogenic variants have been identified in individuals with typical Klippel-Trenaunay syndrome [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013a.173">Revencu et al 2013a</a>].</p></div></dd><dt>8. </dt><dd><div id="rasa1-rel-dis.TF.3.8"><p class="no_margin"><i>PTEN</i> hamartoma tumor syndromes include Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, <i>PTEN</i>-Proteus syndrome, and Proteus-like syndrome.</p></div></dd><dt>9. </dt><dd><div id="rasa1-rel-dis.TF.3.9"><p class="no_margin"><a class="bk_pop" href="#rasa1-rel-dis.REF.caux.2007.767">Caux et al [2007]</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.tan.2007.594">Tan et al [2007]</a></p></div></dd><dt>10. </dt><dd><div id="rasa1-rel-dis.TF.3.10"><p class="no_margin">Hereditary GVMs have a cobblestone appearance with a consistency harder than that of venous malformations. Histologically, glomuvenous malformations are distinguishable by the presence of pathognomonic rounded cells (glomus cells) around the distended vein-like channels [<a class="bk_pop" href="#rasa1-rel-dis.REF.brouillard.2002.866">Brouillard et al 2002</a>].</p></div></dd></dl></div></div></div><p><b>Hereditary benign telangiectasia</b> (OMIM <a href="https://omim.org/entry/187260" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">187260</a>). Some of the cutaneous AVMs in the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorder hereditary benign telangiectasia (HBT) can be of similar size to those seen in CM-AVM syndrome. However, solid organ AVMs are not seen in HBT.</p><p><b>Deletion 5q14.3q15.</b> Individuals with microdeletion of 5q14.3q15 including <i>RASA1</i> and neighboring genes have been reported [<a class="bk_pop" href="#rasa1-rel-dis.REF.carr.2011.1640">Carr et al 2011</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.zweier.2012.164">Zweier &#x00026; Rauch 2012</a>]. Findings included multifocal CMs and severe developmental delay associated with <i>MEF2C</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. In their review of the findings in four other individuals previously reported with deletions of both <i>RASA1</i> and <i>MEF2C</i>, <a class="bk_pop" href="#rasa1-rel-dis.REF.carr.2011.1640">Carr et al [2011]</a> determined that CMs had not been reported, but the report by <a class="bk_pop" href="#rasa1-rel-dis.REF.zweier.2012.164">Zweier and Rauch [2012]</a> showed images of a child with multiple round capillary malformations of variable sizes. The severe developmental delays are not thought to result from <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>RASA1</i>.</p></div><div id="rasa1-rel-dis.Genetically_Related_Alleli"><h2 id="_rasa1-rel-dis_Genetically_Related_Alleli_">Genetically Related (Allelic) Disorders</h2><p><b><i>RASA1.</i></b> No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>RASA1</i>.</p><p>Developmental delay and severe neurologic findings were reported in individuals with deletions encompassing <i>RASA1</i> and <i>MEF2C</i> [<a class="bk_pop" href="#rasa1-rel-dis.REF.carr.2011.1640">Carr et al 2011</a>], but it is thought that these findings are not secondary to <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>RASA1</i>. (See <a href="#rasa1-rel-dis.Management">Differential Diagnosis</a>.)</p><p><b><i>EPHB4</i>.</b> No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>EPHB4</i>.</p></div><div id="rasa1-rel-dis.Management"><h2 id="_rasa1-rel-dis_Management_">Management</h2><div id="rasa1-rel-dis.Evaluations_Following_Init"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with capillary malformation-arteriovenous malformation (CM-AVM) syndrome, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Medical history and physical examination with a focus on symptoms and findings secondary to arteriovenous malformations/arteriovenous fistulas (AVMs/AVFs)</div></li><li class="half_rhythm"><div>Brain imaging &#x02013; if not already performed &#x02013; to identify AVMs/AVFs (e.g., vein of Galen aneurysms and other intracranial AVMs) to allow early identification of macrofistulas that can be treated prior to the development of symptoms [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>]</div></li><li class="half_rhythm"><div>Consideration of spine imaging to identify and characterize AVMs/AVFs. Currently no consensus protocols for radiographic evaluation of individuals with CM-AVM syndrome have been developed; therefore, discussion with a radiologist is recommended in order to develop an appropriate plan for imaging based on the patient's age and the capabilities and experience of the imaging facility.</div></li><li class="half_rhythm"><div>Consideration of further imaging in individuals with evidence of cardiac overload, to look for causative AVMs/AVFs</div></li><li class="half_rhythm"><div>Evaluation for evidence of epistaxis (nosebleeds), and if present, referral to otolaryngologist as appropriate. If epistaxis is present, consider complete blood count for evaluation of anemia.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="rasa1-rel-dis.Treatment_of_Manifestation"><h3>Treatment of Manifestations</h3><div id="rasa1-rel-dis.T.treatment_of_manifestati" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with CM-AVM Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK52764/table/rasa1-rel-dis.T.treatment_of_manifestati/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rasa1-rel-dis.T.treatment_of_manifestati_lrgtbl__"><table><thead><tr><th id="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>CMs &#x00026; telangiectases</b></td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to dermatologist</td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate CMs of cosmetic concern &#x00026; discuss risks &#x00026; benefits of intervention</td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>AVMs/AVFs</b></td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary team incl specialists in interventional radiology, neurosurgery, surgery, cardiology, &#x00026; dermatology depending on location &#x00026; symptoms</td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To determine treatment (e.g., embolization vs surgery)</div></li><li class="half_rhythm"><div>Risks &#x00026; benefits of intervention for AVMs &#x00026; AVFs must be considered.</div></li></ul></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac overload</b></td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to cardiologist</td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hemihyperplasia &#x00026;/or leg length discrepancy</b></td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to orthopedist</td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider:
<ul><li class="half_rhythm"><div>Lymphangiography to evaluate for lymphatic malformations</div></li><li class="half_rhythm"><div>Compression stockings for those w/evidence of lymphedema</div></li></ul></td></tr><tr><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Epistaxis (nosebleeds)</b></td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Humidification &#x00026; nasal lubricants; referral to otolaryngologist</td><td headers="hd_h_rasa1-rel-dis.T.treatment_of_manifestati_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If epistaxis, perform complete blood count for evaluation of anemia.</td></tr></tbody></table></div></div></div><div id="rasa1-rel-dis.Surveillance"><h3>Surveillance</h3><p>The clinician should have a low threshold to repeat imaging studies if clinical signs/symptoms of AVMs/AVFs become evident over time.</p></div><div id="rasa1-rel-dis.AgentsCircumstances_to_Avo"><h3>Agents/Circumstances to Avoid</h3><p>Although no agents/circumstances resulting in complications of CM-AVM syndrome have been reported, a theoretic consideration is avoidance of routine use of anticoagulants unless indicated for treatment of a different medical condition.</p></div><div id="rasa1-rel-dis.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>Clarification of the genetic status of at-risk relatives is appropriate in order to allow early diagnosis and treatment of AVMs/AVFs to reduce/avoid secondary adverse outcomes. In particular, at-risk infants are candidates for prompt diagnosis given the possible early presentation of neurologic complications from intracranial AVMs/AVFs [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>].</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <i>RASA1</i> or <i>EPHB4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known;</div></li><li class="half_rhythm"><div>Physical evaluation of the skin to look for capillary malformations if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known.</div></li></ul><p>See <a href="#rasa1-rel-dis.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="rasa1-rel-dis.Therapies_Under_Investigat"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="rasa1-rel-dis.Genetic_Counseling"><h2 id="_rasa1-rel-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="rasa1-rel-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Capillary malformation-arteriovenous malformation (CM-AVM) syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="rasa1-rel-dis.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>About 70% of individuals diagnosed with <i>RASA1</i>-CM-AVM syndrome have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; about 80% of individuals diagnosed with <i>EPHB4</i>-CM-AVM syndrome have an affected parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with CM-AVM syndrome may have the disorder as the result of a <i>de novo RASA1</i> or <i>EPHB4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In <i>RASA1</i>-CM-AVM syndrome, approximately 30% of probands have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</a>]; in <i>EPHB4</i>-CM-AVM syndrome, approximately 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a <i>de novo</i> pathogenic variant [<a class="bk_pop" href="#rasa1-rel-dis.REF.vivanti.2018.979">Vivanti et al 2018</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>]. Note: Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a <i>de novo</i>
<i>EPHB4</i> pathogenic variant (identified in ~20% of blood cells) was reported in one affected proband [<a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Although no instances of parental germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>The family history of an individual diagnosed with CV-AVM syndrome may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>RASA1</i> or <i>EPHB4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#rasa1-rel-dis.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for CV-AVM syndrome because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with a CV-AVM syndrome has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>RASA1</i> or <i>EPHB4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="rasa1-rel-dis.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#rasa1-rel-dis.Evaluation_of_Relatives_at">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="rasa1-rel-dis.Prenatal_Testing_and_Preim"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the CV-AVM syndrome causative <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk for CV-AVM syndrome and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="rasa1-rel-dis.Resources"><h2 id="_rasa1-rel-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><p>No specific resources for Capillary Malformation-Arteriovenous Malformation Syndrome have been identified by <i>GeneReviews</i> staff.</p></div><div id="rasa1-rel-dis.Molecular_Genetics"><h2 id="_rasa1-rel-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="rasa1-rel-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Capillary Malformation-Arteriovenous Malformation Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK52764/table/rasa1-rel-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rasa1-rel-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EPHB4</i></a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2050" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P54760" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ephrin type-B receptor 4</a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EPHB4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EPHB4</a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EPHB4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EPHB4</a></td></tr><tr><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5921" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RASA1</i></a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5921" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P20936" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ras GTPase-activating protein 1</a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://arup.utah.edu/database/RASA1/RASA1_display.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ARUP RASA1 Database</a><br /><a href="http://proteomics.bio21.unimelb.edu.au/lovd/genes/RASA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RASA1 - LOVD</a><br /><a href="http://structure.bmc.lu.se/idbase/RASA1base/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RASA1base: Database for pathogenic mutations in the RasGAP SH2 domain</a><br /><a href="http://lovd.nl/RASA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vascular Anomaly and Lymphedema Mutation Database - RASA1</a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RASA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RASA1</a></td><td headers="hd_b_rasa1-rel-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RASA1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RASA1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="rasa1-rel-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="rasa1-rel-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Capillary Malformation-Arteriovenous Malformation Syndrome (<a href="/omim/139150,600011,608354,618196" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK52764/table/rasa1-rel-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rasa1-rel-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/139150" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">139150</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RAS p21 PROTEIN ACTIVATOR 1; RASA1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600011" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600011</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPHRIN RECEPTOR EphB4; EPHB4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608354" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608354</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1; CMAVM1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/618196" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">618196</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2; CMAVM2</td></tr></tbody></table></div></div><div id="rasa1-rel-dis.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The protein RASA1 switches the active GTP-bound Ras to the inactive GDP-bound form. It is a negative regulator of the Ras/MAPK-signaling pathway, which mediates cellular growth, differentiation, and proliferation from various protein kinases on cell surfaces.</p><p>Germline <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>RASA1</i> pathogenic variants result in constitutive activation of Ras and resistance to GTPase-activating proteins GAPs.</p><p>EPHB4 and its ligand, EphrinB2, are transmembrane proteins, receptor and ligand, respectively. These two proteins act in concert with Notch signaling to control arterial-venous differentiation. EphrinB2-EPHB4 interactions suppress RAS-MAPK-ERK1/2 and P13K-AKT-MTORC1 pathways [<a class="bk_pop" href="#rasa1-rel-dis.REF.xiao.2012.630">Xiao et al 2012</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>]. EPHB4 is expressed in venous endothelial cells during vascular development [<a class="bk_pop" href="#rasa1-rel-dis.REF.adams.1999.295">Adams et al 1999</a>] and lack of the protein may lead to disorganized vascular development.</p><p><b>Mechanism of disease causation.</b> Based on the currently identified pathogenic variants in <i>RASA1</i>, <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> is a suggested mechanism for the disease. Second hits have been proposed as a mechanism for development of the vascular lesions [<a class="bk_pop" href="#rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.macmurdo.2016.1450">Macmurdo et al 2016</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.lapinski.2018.11">Lapinski et al 2018</a>].</p><p>Loss of function of <i>EPHB4</i> is a suggested mechanism. <i>EPHB4</i> pathogenic variants reported include <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants [<a class="bk_pop" href="#rasa1-rel-dis.REF.amyere.2017.1037">Amyere et al 2017</a>, <a class="bk_pop" href="#rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue et al 2019</a>].</p></div></div><div id="rasa1-rel-dis.References"><h2 id="_rasa1-rel-dis_References_">References</h2><div id="rasa1-rel-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.adams.1999.295">Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. <span><span class="ref-journal">Genes Dev. </span>1999;<span class="ref-vol">13</span>:295–306.</span> [<a href="/pmc/articles/PMC316426/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC316426</span></a>] [<a href="/pubmed/9990854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9990854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.amyere.2017.1037">Amyere M, Revencu N, Helaers R, Pairet E, Baselga E, Cordisco M, Chung W, Dubois J, Lacour JP, Martorell L, Mazereeuw-Hautier J, Pyeritz RE, Amor DJ, Bisdorff A, Blei F, Bombei H, Dompmartin A, Brooks D, Dupont J, Gonz&#x000e1;lez-Ense&#x000f1;at MA, Frieden I, G&#x000e9;rard M, Kvarnung M, Hanson-Kahn AK, Hudgins L, L&#x000e9;aut&#x000e9;-Labr&#x000e8;ze C, McCuaig C, Metry D, Parent P, Paul C, Petit F, Phan A, Quere I, Salhi A, Turner A, Vabres P, Vicente A, Wargon O, Watanabe S, Weibel L, Wilson A, Willing M, Mulliken JB, Boon LM, Vikkula M. Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling. <span><span class="ref-journal">Circulation. </span>2017;<span class="ref-vol">136</span>:1037–48.</span> [<a href="/pubmed/28687708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28687708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.brouillard.2002.866">Brouillard P, Boon LM, Mulliken JB, Enjolras O, Ghassibe M, Warman ML, Tan OT, Olsen BR, Vikkula M. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ('glomangiomas'). <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:866–74.</span> [<a href="/pmc/articles/PMC379115/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379115</span></a>] [<a href="/pubmed/11845407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11845407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.buhl.2012.1334">Buhl T, Shoukier M, Grzmil P, Revencu N, Schon MP, Seitz CS. Multifocal capillary malformations due to RASA1 mutation misdiagnosed as cutaneous mastocytosis. <span><span class="ref-journal">Arch Dermatol. </span>2012;<span class="ref-vol">148</span>:1334–5.</span> [<a href="/pubmed/23165854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23165854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.burrows.2013.8621">Burrows PE, Gonzalez-Garay ML, Rasmussen JC, Aldrich MB, Guilliod R, Maus EA, Fife CE, Kwon S, Lapinski PE, King PD, Sevick-Muraca EM. Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2013;<span class="ref-vol">110</span>:8621–6.</span> [<a href="/pmc/articles/PMC3666675/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3666675</span></a>] [<a href="/pubmed/23650393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23650393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.carr.2011.1640">Carr CW, Zimmerman HH, Martin CH, Vikkula M, Byrd AC, Abdul-Rahman OA. 5q14.3 Neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1640–5.</span> [<a href="/pubmed/21626678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21626678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.catal_.2013.710">Catal&#x000e0; A, Ro&#x000e9; E, Vikkula M, Baselga E. Capillary malformation-arteriovenous malformation syndrome: a report of 2 cases, diagnostic criteria, and management. <span><span class="ref-journal">Actas Dermosifiliogr. </span>2013;<span class="ref-vol">104</span>:710–3.</span> [<a href="/pubmed/23933248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23933248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.caux.2007.767">Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P, Bonnet F, Selma ZB, Laroche L, G&#x000e9;rard M, Longy M. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:767–73.</span> [<a href="/pubmed/17392703" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17392703</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.de_wijn.2012.191">de Wijn RS, Oduber CE, Breugem CC, Alders M, Hennekam RC, van der Horst CM. Phenotypic variability in a family with capillary malformations caused by a mutation in the RASA1 gene. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:191–5.</span> [<a href="/pubmed/22342634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22342634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.durrington.2013.1690">Durrington HJ, Firth HV, Patient C, Belham M, Jayne D, Burrows N, Morrell NW, Chilvers ER. A novel RASA1 mutation causing capillary malformation-arteriovenous malformation (CM-AVM) presenting during pregnancy. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:1690–4.</span> [<a href="/pubmed/23687085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23687085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.eerola.2003.1240">Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, Vanwijck R, Vikkula M. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. <span><span class="ref-journal">Am J Hum Genet. </span>2003;2003;<span class="ref-vol">73</span>:1240–9.</span> [<a href="/pmc/articles/PMC1180390/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180390</span></a>] [<a href="/pubmed/14639529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14639529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.grillner.2016.709">Grillner P, Soderman M, Holmin S, Rodesch G. A spectrum of intracranial vascular high-flow arteriovenous shunts in RASA1 mutations. <span><span class="ref-journal">Childs Nerv Syst. </span>2016;<span class="ref-vol">32</span>:709–15.</span> [<a href="/pubmed/26499346" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26499346</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.hershkovitz.2008a.1035">Hershkovitz D, Bercovich D, Sprecher E, Lapidot M. RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations. <span><span class="ref-journal">Br J Dermatol. </span>2008a;<span class="ref-vol">158</span>:1035–40.</span> [<a href="/pubmed/18363760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18363760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.hershkovitz.2008b.385">Hershkovitz D, Bergman R, Sprecher E. A novel mutation in RASA1 causes capillary malformation and limb enlargement. <span><span class="ref-journal">Arch Dermatol Res. </span>2008b;<span class="ref-vol">300</span>:385–8.</span> [<a href="/pubmed/18327598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18327598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.kim.2015.128">Kim C, Ko CJ, Baker KE, Antaya RJ. Histopathologic and ultrasound characteristics of cutaneous capillary malformations in a patient with capillary malformation-arteriovenous malformation syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2015;<span class="ref-vol">32</span>:128–31.</span> [<a href="/pubmed/23829194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23829194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.lapinski.2018.11">Lapinski PE, Doosti A, Salato V, North P, Burrows PE, King PD. Somatic second hit mutation of RASA1 in vascular endothelial cells in capillary malformation-arteriovenous malformation. <span><span class="ref-journal">Eur J Med Genet. </span>2018;<span class="ref-vol">61</span>:11–6.</span> [<a href="/pmc/articles/PMC5766414/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5766414</span></a>] [<a href="/pubmed/29024832" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29024832</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.li.2018.3233">Li D, Wenger TL, Seiler C, March ME, Gutierrez-Uzquiza A, Kao C, Bhoj E, Tian L, Rosenbach M, Liu Y, Robinson N, Behr M, Chiavacci R, Hou C, Wang T, Bakay M, Pellegrino da Silva R, Perkins JA, Sleiman P, Levine MA, Hicks PJ, Itkin M, Dori Y, Hakonarson H. Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly. <span><span class="ref-journal">Hum Mol Genet. </span>2018;<span class="ref-vol">27</span>:3233–45.</span> [<a href="/pubmed/29905864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29905864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.macmurdo.2016.1450">Macmurdo CF, Wooderchak-Donahue W, Bayrak-Toydemir P, Le J, Wallenstein MB, Milla C, Teng JM, Bernstein JA, Stevenson DA. RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:1450–4.</span> [<a href="/pubmed/26969842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26969842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.martinalmedina.2016.3080">Martin-Almedina S, Martinez-Corral I, Holdhus R, Vicente A, Fotiou E, Lin S, Petersen K, Simpson MA, Hoischen A, Gilissen C, Jeffery H, Atton G, Karapouliou C, Brice G, Gordon K, Wiseman JW, Wedin M, Rockson SG, Jeffery S, Mortimer PS, Snyder MP, Berland S, Mansour S, Makinen T, Ostergaard P. EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis. <span><span class="ref-journal">J Clin Invest. </span>2016;<span class="ref-vol">126</span>:3080–8.</span> [<a href="/pmc/articles/PMC4966301/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4966301</span></a>] [<a href="/pubmed/27400125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27400125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.maruani.2018.251">Maruani A, Durieux-Verde M, Mazereeuw-Hautier J, Boccara O, Martin L, Chiaverini C, Eschard C, B&#x000e9;n&#x000e9;ton N, Vabres P, Balguerie X, Plantin P, Bessis D, Barbarot S, Dadban A, Droitcourt C, Berthelot A, Lorette G, Leducq S, Samimi M, Andres C, Caille A, Vourc'h P, et al.  Search for RASA1 variants in capillary malformations of the legs in 113 children: results from the French National Paediatric Cohort CONAPE. <span><span class="ref-journal">Acta Derm Venereol. </span>2018;<span class="ref-vol">98</span>:251–5.</span> [<a href="/pubmed/29110021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29110021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.mulliken.1988">Mulliken JB, Young AE, eds. <em>Vascular Birthmarks: Hemangiomas and Vascular Malformations</em>. Philadelphia, PA: WB Saunders Co; 1988.</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.oduber.2008.217">Oduber CE, van der Horst CM, Hennekam RC. Klippel-Trenaunay syndrome: diagnostic criteria and hypothesis on etiology. <span><span class="ref-journal">Ann Plast Surg. </span>2008;<span class="ref-vol">60</span>:217–23.</span> [<a href="/pubmed/18216519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18216519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.orme.2013.409">Orme CM, Boyden LM, Choate KA, Antaya RJ, King BA. Capillary malformation--arteriovenous malformation syndrome: review of the literature, proposed diagnostic criteria, and recommendations for management. <span><span class="ref-journal">Pediatr Dermatol. </span>2013;<span class="ref-vol">30</span>:409–15.</span> [<a href="/pubmed/23662773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23662773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.overcash.2015.2440">Overcash RT, Gibu CK, Jones MC, Ramos GA, Andreasen TS. Maternal and fetal capillary malformation-arteriovenous malformation (CM-AVM) due to a novel RASA1 mutation presenting with prenatal non-immune hydrops fetalis. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2440–3.</span> [<a href="/pubmed/26096958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26096958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.revencu.2013a.173">Revencu N, Boon LM, Dompmartin A, Rieu P, Busch WL, Dubois J, Forzano F, van Hagen JM, Halbach S, Kuechler A, Lachmeijer AM, L&#x000e4;hde J, Russell L, Simola KO, Mulliken JB, Vikkula M. Germline mutations in RASA1 are not found in patients with Klippel-Trenaunay syndrome or capillary malformation with limb overgrowth. <span><span class="ref-journal">Mol Syndromol. </span>2013a;<span class="ref-vol">4</span>:173–8.</span> [<a href="/pmc/articles/PMC3666457/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3666457</span></a>] [<a href="/pubmed/23801933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23801933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, Hammer F, Amor DJ, Irvine AD, Baselga E, Dompmartin A, Syed S, Santiago AM, Ades L, Collins F, Smith J, Sandaradura S, Barrio VR, Burrows PE, Blei F, Cozzolino M, Brunetti-Pierri N, Vicente A, Abramowicz M, D&#x000e9;sir J, Vilain C, Chung WK, Wilson A, Gardiner CA, Dwight Y, Lord DJ, Fishman L, Cytrynbaum C, Chamlin S, Ghali F, Gilaberte Y, Joss S, Boente MD, L&#x000e9;aut&#x000e9;-Labr&#x000e8;ze C, Delrue MA, Bayliss S, Martorell L, Gonzalez MA, Mazereeuw-Hautier J, O'Donnell B, Bessis D, Pyeritz RE, Salhi A, Tan OT, Wargon O, Mulliken JB, Vikkula M. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. <span><span class="ref-journal">Hum Mutat. </span>2013b;<span class="ref-vol">34</span>:1632–41.</span> [<a href="/pubmed/24038909" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24038909</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.revencu.2008.959">Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, Clapuyt P, Hammer F, Dubois J, Baselga E, Brancati F, Carder R, Quintal JM, Dallapiccola B, Fischer G, Frieden IJ, Garzon M, Harper J, Johnson-Patel J, Labr&#x000e8;ze C, Martorell L, Paltiel HJ, Pohl A, Prendiville J, Quere I, Siegel DH, Valente EM, Van Hagen A, Van Hest L, Vaux KK, Vicente A, Weibel L, Chitayat D, Vikkula M. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:959–65.</span> [<a href="/pubmed/18446851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18446851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.shirley.2013.1971">Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, North PE, Marchuk DA, Comi AM, Pevsner J. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">368</span>:1971–9.</span> [<a href="/pmc/articles/PMC3749068/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3749068</span></a>] [<a href="/pubmed/23656586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23656586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.tan.2007.594">Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB, Fishman SJ, Irons MB. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:594–602.</span> [<a href="/pmc/articles/PMC2597949/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2597949</span></a>] [<a href="/pubmed/17526801" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17526801</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.thiex.2010.775">Thiex R, Mulliken JB, Revencu N, Boon LM, Burrows PE, Cordisco M, Dwight Y, Smith ER, Vikkula M, Orbach DB. A novel association between RASA1 mutations and spinal arteriovenous anomalies. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2010;<span class="ref-vol">31</span>:775–9.</span> [<a href="/pubmed/20007727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20007727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.vahidnezhad.2016.17">Vahidnezhad H, Youssefian L, Uitto J. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). <span><span class="ref-journal">Exp Dermatol. </span>2016;<span class="ref-vol">25</span>:17–9.</span> [<a href="/pubmed/26268729" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26268729</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.vivanti.2018.979">Vivanti A, Ozanne A, Grondin C, Saliou G, Quevarec L, Maurey H, Aubourg P, Benachi A, Gut M, Gut I, Martinovic J, S&#x000e9;nat MV, Tawk M, Melki J. Loss of function mutations in EPHB4 are responsible for vein of Galen aneurysmal malformation. <span><span class="ref-journal">Brain. </span>2018;<span class="ref-vol">141</span>:979–88.</span> [<a href="/pubmed/29444212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29444212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.weitz.2015.76">Weitz NA, Lauren CT, Behr GG, Wu JK, Kandel JJ, Meyers PM, Sultan S, Anyane-Yeboa K, Morel KD, Garzon MC. Clinical spectrum of capillary malformation-arteriovenous malformation syndrome presenting to a pediatric dermatology practice: a retrospective study. <span><span class="ref-journal">Pediatr Dermatol. </span>2015;<span class="ref-vol">32</span>:76–84.</span> [<a href="/pubmed/25040287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25040287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.wooderchakdonahue.2012.91">Wooderchak-Donahue W, Stevenson DA, McDonald J, Grimmer JF, Gedge F, Bayrak-Toydemir P. RASA1 analysis: clinical and molecular findings in a series of consecutive cases. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:91–5.</span> [<a href="/pubmed/22200646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22200646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.wooderchakdonahue.2019.2007">Wooderchak-Donahue WL, Akay G, Whitehead K, Briggs E, Stevenson DA, O'Fallon B, Velinder M, Farrell A, Shen W, Bedoukian E, Skrabann CM, Antaya RJ, Henderson K, Pollak J, Treat J, Day R, Jacher JE, Hannibal M, Bontempo K, Marth G, Bayrak-Toydemir P, McDonald J. Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)? <span><span class="ref-journal">Genet Med. </span>2019;<span class="ref-vol">21</span>:2007–14.</span> [<a href="/pubmed/30760892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30760892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.wooderchakdonahue.2018.1521">Wooderchak-Donahue WL, Johnson P, McDonald J, Blei F, Berenstein A, Sorscher M, Mayer J, Scheuerle AE, Lewis T, Grimmer JF, Richter GT, Steeves MA, Lin AE, Stevenson DA, Bayrak-Toydemir P. Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation. <span><span class="ref-journal">Eur J Hum Genet. </span>2018;<span class="ref-vol">26</span>:1521–36.</span> [<a href="/pmc/articles/PMC6138627/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6138627</span></a>] [<a href="/pubmed/29891884" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29891884</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.xiao.2012.630">Xiao Z, Carrasco R, Kinneer K, Sabol D, Jallal B, Coats S, Tice DA. EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: implications for EphB4 as a cancer target. <span><span class="ref-journal">Cancer Biol Ther. </span>2012;<span class="ref-vol">13</span>:630–7.</span> [<a href="/pubmed/22555806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22555806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.zhou.2011.603">Zhou Q, Zheng JW, Yang XJ, Wang HJ, Ma D, Qin ZP. Detection of RASA1 mutations in patients with sporadic Sturge-Weber syndrome. <span><span class="ref-journal">Childs Nerv Syst. </span>2011;<span class="ref-vol">27</span>:603–7.</span> [<a href="/pubmed/20821215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20821215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rasa1-rel-dis.REF.zweier.2012.164">Zweier M, Rauch A. The MEF2C-related and 5q14.3q15 microdeletion syndrome. <span><span class="ref-journal">Mol Syndromol. </span>2012;<span class="ref-vol">2</span>:164–70.</span> [<a href="/pmc/articles/PMC3366707/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3366707</span></a>] [<a href="/pubmed/22670137" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22670137</span></a>]</div></li></ul></div></div><div id="rasa1-rel-dis.Chapter_Notes"><h2 id="_rasa1-rel-dis_Chapter_Notes_">Chapter Notes</h2><div id="rasa1-rel-dis.Acknowledgments"><h3>Acknowledgments</h3><p>We acknowledge Dr Johannes Fredrik Grimmer for his insights.</p></div><div id="rasa1-rel-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>12 September 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 October 2016 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 December 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 February 2011 (me) Review posted live</div></li><li class="half_rhythm"><div>6 December 2010 (pbt) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK52764</span><span class="label">PMID: <a href="/pubmed/21348050" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21348050</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cantu/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ca5a-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK52764&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK52764/?report=reader">PubReader</a></li><li><a href="/books/NBK52764/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK52764" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK52764" style="display:none" title="Cite this Page"><div class="bk_tt">Bayrak-Toydemir P, Stevenson D. Capillary Malformation-Arteriovenous Malformation Syndrome. 2011 Feb 22 [Updated 2019 Sep 12]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK52764/pdf/Bookshelf_NBK52764.pdf">PDF version of this page</a> (478K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#rasa1-rel-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#rasa1-rel-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#rasa1-rel-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#rasa1-rel-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#rasa1-rel-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#rasa1-rel-dis.Genetically_Related_Alleli" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#rasa1-rel-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#rasa1-rel-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#rasa1-rel-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#rasa1-rel-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#rasa1-rel-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#rasa1-rel-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2050[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EPHB4</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5921[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RASA1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2412772" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2412772" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2412772" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2412772" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26969842" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.</a><span class="source">[Am J Med Genet A. 2016]</span><div class="brieflinkpop offscreen_noflow">RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Macmurdo CF, Wooderchak-Donahue W, Bayrak-Toydemir P, Le J, Wallenstein MB, Milla C, Teng JM, Bernstein JA, Stevenson DA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2016 Jun; 170(6):1450-4. Epub 2016 Mar 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30056992" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Multiple capillary malformations of progressive onset: Capillary malformation-arteriovenous malformation syndrome (CM-AVM).</a><span class="source">[Ann Dermatol Venereol. 2018]</span><div class="brieflinkpop offscreen_noflow">Multiple capillary malformations of progressive onset: Capillary malformation-arteriovenous malformation syndrome (CM-AVM).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gourier G, Audebert-Bellanger S, Vourc'h P, Fraitag S, L'Hérondelle K, Labouche A, Misery L, Abasq-Thomas C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Dermatol Venereol. 2018 Aug - Sep; 145(8-9):486-491. Epub 2018 Jul 26.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27625812" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">RASA1 analysis guides management in a family with capillary malformation-arteriovenous malformation.</a><span class="source">[J Pediatr Genet. 2012]</span><div class="brieflinkpop offscreen_noflow">RASA1 analysis guides management in a family with capillary malformation-arteriovenous malformation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Flore LA, Leon E, Maher TA, Milunsky JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr Genet. 2012 Jun; 1(2):125-9. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301525" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Hemorrhagic Telangiectasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Hemorrhagic Telangiectasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McDonald J, Pyeritz RE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21348050" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21348050" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc932975f66d18aadf81af">Capillary Malformation-Arteriovenous Malformation Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Capillary Malformation-Arteriovenous Malformation Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:23:53-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B9F1CDFC880410000000005740286&amp;ncbi_session=CE8B9F1CDFC93291_1396SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK52764%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK52764&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK52764/&amp;ncbi_pagename=Capillary Malformation-Arteriovenous Malformation Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B9F1CDFC93291_1396SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>